// App-Quantinova.ai

1698 : Novel evidence that blood plasma vitronectin is a major chemoattractant for cancer cells and its pro-migratory activity is suppressed/chaperoned after binding to fibrinogen

Researchers

Presenter

  • Gabriela Schneider

Principal Investigators

  • Nichola C. Garbett

  • Ewa Bryndza

  • Agata Poniewierska-Baran

  • Michael L. Merchant

  • Karol Serwin

  • Zachariah P. Sellers

  • Barbara Dolegowska

  • Mariusz Z. Ratajczak

Medical Centers

  • The University of Louisville, Louisville, KY

  • Pomeranian Medical University, Szczecin, Poland

Locations

  • United States

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Hepatocyte growth factor

  • Stromal cell-derived factor 1

Drug/Treatment

  • Fibrinogen (IV)

  • SDF-1

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved